These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11561179)

  • 21. [Statins and cardiovascular disease prevention: use and prospective].
    Moulin P
    Nephrologie; 2000; 21(7):379-80. PubMed ID: 11200617
    [No Abstract]   [Full Text] [Related]  

  • 22. Cholesterol lowering with statin drugs: evidence in women.
    Wagner MB
    JAMA; 1997 Nov; 278(20):1660-1. PubMed ID: 9388082
    [No Abstract]   [Full Text] [Related]  

  • 23. Pravastatin versus simvastatin--what happens in the real world?
    Levenstein S
    S Afr Med J; 1995 May; 85(5):388-91. PubMed ID: 7638696
    [No Abstract]   [Full Text] [Related]  

  • 24. Simvastatin in the media.
    Watt G; Galbraith W
    N Z Med J; 1989 Dec; 102(881):651-2. PubMed ID: 2608245
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical implications of new drugs for lowering plasma cholesterol concentrations.
    Illingworth DR
    Drugs; 1991 Feb; 41(2):151-60. PubMed ID: 1709846
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin.
    Emmerich J
    Am J Cardiol; 1994 Apr; 73(9):723-4. PubMed ID: 8166080
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosuvastatin and primary cardiovascular prevention. Continue to use pravastatin or simvastatin.
    Prescrire Int; 2011 Apr; 20(115):94. PubMed ID: 21648210
    [No Abstract]   [Full Text] [Related]  

  • 29. Statin-stimulated nitric oxide release from endothelium.
    Dobrucki LW; Kalinowski L; Dobrucki IT; Malinski T
    Med Sci Monit; 2001; 7(4):622-7. PubMed ID: 11433186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of simvastatin on serum lipids and atherosclerosis in WHHL rabbits.
    Fukuo Y; Nagashima M; Saitoh A; Kobayashi Y; Terashi A; Nakama K; Kameyama K; Asano G
    Clin Ther; 1991; 13(3):417-24. PubMed ID: 1954642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Pincus J
    Am J Cardiol; 1998 Aug; 82(3):406-7. PubMed ID: 9708683
    [No Abstract]   [Full Text] [Related]  

  • 32. HDL cholesterol: metabolic pathways and drug developments. Fifth Annual International Conference of the Knowledge Foundation. March 8-9, 2004, Cambridge, MA, USA.
    Scriabine A
    Cardiovasc Drug Rev; 2004; 22(2):147-53. PubMed ID: 15499703
    [No Abstract]   [Full Text] [Related]  

  • 33. Statins and fibrates in the management of diabetic dyslipidemia.
    Durrington P
    Diabet Med; 1997 Jul; 14(7):513-6. PubMed ID: 9223386
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of hyperlipidemia after heart transplantation and rationale for the Heart Transplant Lipid Registry.
    Ballantyne CM; Bourge RC; Domalik LJ; Eisen HJ; Fishbein DP; Kubo SH; Lake KD; Radovancevic B; Taylor DO; Ventura HO; Yancy CW; Young JB
    Am J Cardiol; 1996 Sep; 78(5):532-5. PubMed ID: 8806337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fixed-dose combination fenofibrate/pravastatin 160/40 mg versus simvastatin 20 mg monotherapy in adults with type 2 diabetes and mixed hyperlipidemia uncontrolled with simvastatin 20 mg: a double-blind, randomized comparative study.
    Farnier M; Steinmetz A; Retterstøl K; Császár A
    Clin Ther; 2011 Jan; 33(1):1-12. PubMed ID: 21397769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress.
    Andreadou I; Farmakis D; Prokovas E; Sigala F; Zoga A; Spyridaki K; Papalois A; Papapetropoulos A; Anastasiou-Nana M; Kremastinos DT; Iliodromitis EK
    Cardiovasc Res; 2012 Jun; 94(3):501-9. PubMed ID: 22411971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved survival with statin therapy.
    Clem JR
    S D J Med; 1996 Aug; 49(8):273-4. PubMed ID: 8803474
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperlipidaemia and cardiovascular disease.
    Wright R; Northridge D
    Curr Opin Lipidol; 1996 Jun; 7(3):U92-8. PubMed ID: 8818521
    [No Abstract]   [Full Text] [Related]  

  • 39. Comment on: effect of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.
    Mikhailidis DP; Ganotakis ES; Winder AF
    Atherosclerosis; 1996 Dec; 127(2):287-90. PubMed ID: 9125320
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)].
    Golay A; Lehmann T; James R; Pometta D
    Schweiz Med Wochenschr; 1993 Aug; 123(33):1553-8. PubMed ID: 8372340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.